Skip to main content
Top
Published in:

Open Access 01-12-2025 | Metabolic and Bariatric Surgery | REVIEW

Is There a Need to Reassess Protein Intake Recommendations Following Metabolic Bariatric Surgery?

Authors: Tair Ben-Porat, Yair Lahav, Tamara R. Cohen, Simon L. Bacon, Assaf Buch, Violeta Moizé, Shiri Sherf-Dagan

Published in: Current Obesity Reports | Issue 1/2025

Login to get access

Abstract

Purpose of Review

Protein intake is recognized as a key nutritional factor crucial for optimizing Metabolic Bariatric Surgery (MBS) outcomes by preventing protein malnutrition, preserving fat-free mass, and inducing satiety. This paper discusses the current evidence regarding protein intake and its impact on clinical outcomes following MBS.

Recent Findings

There are considerable gaps in the understanding of protein requirements following MBS, as existing guidelines are based on limited and inconsistent reports. This highlights the urgent need for updated clinical practice recommendations grounded in high-quality evidence.

Summary

Further investigation using robust methodologies is essential to address existing research gaps related to the individualization of protein requirements following MBS. Future research should consider factors such as the time elapsed since surgery, the form and quantity of protein consumed, and necessary adjustments for physical activity. Ultimately, in alignment with recent literature, a more specific and personalized dietary protein approach should be examined.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Is There a Need to Reassess Protein Intake Recommendations Following Metabolic Bariatric Surgery?
Authors
Tair Ben-Porat
Yair Lahav
Tamara R. Cohen
Simon L. Bacon
Assaf Buch
Violeta Moizé
Shiri Sherf-Dagan
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Obesity Reports / Issue 1/2025
Electronic ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-025-00607-1

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by: Abbott Diabetes Care

Watch the full video

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025: the 85th Scientific Sessions

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s annual meeting.

Read more